Insmed
INSM
#910
Rank
โ‚ฌ23.97 B
Marketcap
109,27ย โ‚ฌ
Share price
-1.69%
Change (1 day)
-37.23%
Change (1 year)

EPS for Insmed (INSM)

EPS in 2026 (TTM): -2,43ย โ‚ฌ

According to Insmed's latest financial reports the company's current EPS (TTM) is -2,57ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,85ย โ‚ฌ a decrease over its 2024 EPS that were of -5,10ย โ‚ฌ.

EPS history for Insmed from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,43ย โ‚ฌ-58.5%
2025-5,85ย โ‚ฌ14.67%
2024-5,10ย โ‚ฌ
2022-3,56ย โ‚ฌ0.78%
2021-3,53ย โ‚ฌ28.57%
2020-2,75ย โ‚ฌ-0.99%
2019-2,77ย โ‚ฌ-27.96%
2018-3,85ย โ‚ฌ47.55%
2017-2,61ย โ‚ฌ0.7%
2016-2,59ย โ‚ฌ39.9%
2015-1,85ย โ‚ฌ9.73%
2014-1,69ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
4,79ย โ‚ฌ-286.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-2,83ย โ‚ฌ 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
14,29ย โ‚ฌ-655.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-2,40ย โ‚ฌ-6.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,68ย โ‚ฌ-73.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-1,05ย โ‚ฌ-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA